Pr_tres
![](https://easldhiliconsortium.eu/wp-content/uploads/2022/12/w_autoinmune.jpg)
There is a clear unmet need for a deeper understanding of idiosyncratic drug-induced liver injury (DILI), a multi-layered challenge that spans the life of the drug from pre-clinical development to clinical trials and post-marketing.
![](https://easldhiliconsortium.eu/wp-content/uploads/2022/12/w_labo.jpg)
There is a clear unmet need for a deeper understanding of idiosyncratic drug-induced liver injury (DILI), a multi-layered challenge that spans the life of the drug from pre-clinical development to clinical trials and post-marketing.
![](https://easldhiliconsortium.eu/wp-content/uploads/2022/12/w_statutes.jpg)
There is a clear unmet need for a deeper understanding of idiosyncratic drug-induced liver injury (DILI), a multi-layered challenge that spans the life of the drug from pre-clinical development to clinical trials and post-marketing.